Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1060P (RNA, U6 small nuclear 1060, pseudogene) is an annotated pseudogene in the human genome, similar in sequence to U6 small nuclear RNA, a molecule involved in RNA splicing. Pseudogenes are noncoding gene sequences that have lost protein-coding function due to mutations. While most pseudogenes are considered genomically inactive, some can participate in the regulation of other genes by acting as regulatory RNAs (such as miRNA sponges, antisense RNAs, or sources of small interfering RNAs) and thus contribute indirectly to biological processes. However, there is no evidence that RNU6-1060P plays a direct or therapeutically actionable role, nor are there descriptions of its involvement in disease or as a marker for drug response[1][2][4]. Pseudogenes, in general, may exert effects through epigenetic mechanisms, modulation of gene expression, or serving as competitive endogenous RNAs, but RNU6-1060P has not been specifically implicated in these processes[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1060, pseudogene (RNU6-1060P).